
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1060 | 1005 | 1101 | 1168 | 1458 | 1709 |
Fund Return | 5.97% | 0.53% | 10.12% | 5.31% | 7.84% | 5.51% |
Place in category | 1482 | 1653 | 336 | 312 | 153 | 332 |
% in Category | 69 | 79 | 13 | 17 | 9 | 33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Income Fund C div USD hedged | 16.71B | 2.03 | 3.37 | 4.60 | ||
JPI Global Income Fund C dist USD h | 16.71B | 2.03 | 3.36 | 4.59 | ||
JPI Global Income Fund C mth USD he | 16.71B | 2.06 | 4.01 | 4.38 | ||
JPI Global Income Fund D acc USD he | 16.71B | 1.89 | 2.96 | 3.34 | ||
JPI Global Income Fund D mth USD he | 16.71B | 1.89 | 2.93 | 3.32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS S GS Europe CORE Equity Portfolu | 800.95K | 9.73 | 8.02 | 5.94 | ||
Europe Equity Plus Fund A perf acc | 2.51B | 10.92 | 10.64 | 6.16 | ||
JPMorgan InVs Euro SelectEqA AccUSD | 2.27B | 11.35 | 6.45 | 4.77 | ||
JPMorgan InVs Euro SelectEqD AccUSD | 2.27B | 11.21 | 5.63 | 3.98 | ||
JPEurope Equity Plus Fund C perf ac | 2.51B | 6.26 | 7.88 | 6.92 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 3.91 | 27.95 | -5.25% | |
SAP | DE0007164600 | 3.59 | 221.400 | -4.24% | |
AstraZeneca | GB0009895292 | 2.71 | 10,056.0 | -6.96% | |
Munich Re Group | DE0008430026 | 2.68 | 519.80 | -7.01% | |
Barclays | GB0031348658 | 2.56 | 241.85 | -3.28% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Sell | BUY | Strong Buy |
Summary | Sell | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review